Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
clinical trials
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
sanofi
3
×
cancer
cancer drugs
ipo
revolution medicines
san francisco
the column group
third rock ventures
warp drive bio
abbvie
aimmune therapeutics
akcea therapeutics
akebia therapeutics
alex pinto
amarin pharma
amarna therapeutics
amgen
amylyx
amyotrophic lateral sclerosis (als)
anemia
antibody drug
biofourmis
boston pharmaceuticals
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
casdin capital
chronic kidney disease
clene nanomedicine
cobimetinib
colorectal cancer
What
cancer
3
×
ipo
medicines
proteins
research
revolution
abbvie’s
ahead
bio
biofourmis
bucks
cancer’s
celebrate
chance
corner
day
days
despite
disease
drug
family
forward
frontiers
hardest
hit
holiday
hottest
hunters
known
labor
looking
maps
parlance
people
pharma
pharmaceutical
play
ras
reach
reels
Language
unset
3
×
Current search:
sanofi
×
unset
×
cancer
×
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
